A review of the University of Arizona human clinical hyperthermia experience.
D000230:Adenocarcinoma / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001130:Arizona; D001831:Body Temperature; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects / Q000379:methods*; D007223:Infant; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy; D008872:Microwaves / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D011846:Radio Waves / Q000009:adverse effects; D012509:Sarcoma / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy; D013821:Thermometers; D014464:Ultrasonic Therapy / Q000009:adverse effects
D000970:Antineoplastic Agents